Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04664114 |
Other study ID # |
2020/259 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
February 1, 2020 |
Est. completion date |
October 16, 2020 |
Study information
Verified date |
December 2020 |
Source |
Selcuk University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Aim: This study was conducted to determine the effect of showing images of the fetus to the
pregnant women with the virtual reality glass during labor process on labor pain, birth
perception and anxiety level.
Background: Virtual reality (VR) is an effective and inexpensive method that allows the
creation of simulated scenarios in which it interacts with the virtual environment with
multisensory stimuli.
Methods: This is a randomized controlled experimental study. The study included 100 pregnant
women of whom 50 in the intervention group and 50 in the control group. Ultrasound images of
the fetus were recorded on the 28th week of pregnancy of the women in the intervention group.
These images were shown to the women with the virtual reality glass during labor process.
Routine procedures were carried out for the women in the control group. The Visual Analog
Scale (VAS) was applied to both groups when cervical dilatation was 4 cm and 9 cm. The
Women's Perception for the Scale of Supportive Care Given During Labor (POBS) and the
Perinatal Anxiety Screening Scale (PASS) were applied almost two hours after labor.
Keywords: Virtual reality, labor, pain, anxiety.
Description:
Performed on the pregnant women in the intervention group (Virtual Reality Glass Group-VRGG)
Pregnant women who met the inclusion criteria and were in the 28th weeks of pregnancy were
assigned in the intervention or control group according to the randomization chart when they
came to the Obstetrics and Gynecology Polyclinic for pregnancy follow-up. Pregnant women in
the intervention group were informed about the study, and their verbal and written consent
was obtained. The third author and the Gynecology and Obstetrics Specialist evaluated the
presentation of the baby, amniotic fluid, placenta, umbilical artery doppler, fetal biometry
(BPD, HC, AC, FL) and fetal respiration with the Voluson 730 PRO ultrasound device. In the
remaining time, if the position of the baby is suitable, it was ensured that video images
were recorded on the phone of the pregnant woman by looking at the baby's face with the help
of a 3D / 4D probe. Although it might be performed in earlier and later weeks, such visual
evaluations are made in the 27th-28th weeks since the visualization is better. The ultrasound
session both for the evaluation of the fetus and for visual purposes took 15-20 minutes in
total. These pregnant women were asked to bring their phone that the video was recorded with
them to the labor. When the pregnant women got into labor, they were hospitalized by the
third researcher. The follow-ups and labor were also performed by the third author. These
two-dimensional images were converted into three-dimensional images through an application
installed in the mother's phone and were shown to her with a VR Box 3 D virtual reality glass
one after another. In cases where the program was not compatible with the mother's phone, it
was watched on the researcher's phone. The total duration of image viewing was recorded.
Practices performed on the pregnant women in the control group (Control Group-CG) Pregnant
women who met the inclusion criteria and were in the 28th weeks of pregnancy were assigned to
the control group according to the randomization chart. When the pregnant women got into
labor, they were hospitalized by the third researcher. No practices other than the routine
were applied on pregnant women in the control group. These routine practices are monitoring
pregnant women's cervical dilation, contraction and fetal heart rate, providing freedom of
action, restricting oral intake for labor duration. No oxytocin induction or any analgesic
were applied on the pregnant women in both groups. The rooms where the pregnant women stayed
were kept dim and calm. The pregnant women in the control group were monitored and delivered
by the third author during the labor process. For not hampering the monitoring of pregnant
women, only one pregnant woman was included in the study at the same time. The Visual Analog
Scale (VAS) was applied to both groups when cervical dilatation was 4 cm and 9 cm. The
Women's Perception for the Scale of Supportive Care Given During Labor (POBS) and the
Perinatal Anxiety Screening Scale (PASS) were applied almost two hours after labor (so that
the mother had time to breastfeed the baby and the mother's vital signs were stabilized).